iBio
IBIO
#9788
Rank
NZ$86.32 M
Marketcap
NZ$3.84
Share price
32.93%
Change (1 day)
-18.50%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): NZ-$3.86

According to iBio's latest financial reports the company's current EPS (TTM) is NZ-$3.94. In 2024 the company made an earnings per share (EPS) of NZ-$11.24 an increase over its 2023 EPS that were of NZ-$183.63.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$3.86-65.66%
2024NZ-$11.24-93.88%
2023NZ-$183.63-8.14%
2022NZ-$199.9192.67%
2021NZ-$103.76-80.33%
2020NZ-$527.44-35.11%
2019NZ-$812.77-38.96%
2018NZ-$1,332-6.1%
2017NZ-$1,41836.67%
2016NZ-$1,03833.33%
2015NZ-$778.1950%
2014NZ-$518.79-53.85%
2013NZ-$1,124-7.14%
2012NZ-$1,211-64.1%
2011NZ-$3,37277.27%
2010NZ-$1,902144.44%
2009NZ-$778.1912.93%
2008NZ-$689.1012.2%
2007NZ-$614.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Genocea Biosciences
GNCA
NZ-$0.90-77.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.44-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.05-557.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$7.31 85.53%๐Ÿ‡บ๐Ÿ‡ธ USA